Big US companies, analysts and fund managers will today call for the end of quarterly earnings guidance, saying that chief executives' obsession with meeting forecasts damages shareholders and corporate governance.

The move by an influential slice of corporate America will increase pressure on US-listed groups to follow companies such as Pfizer, Intel and Motorola and stop focusing on short-term, self-imposed targets.